Medical Device Contract Manufacturing Market Size, Share, and Growth Analysis By Product Class (Class I, Class II, Class III), By Service Type (Device Development and Manufacturing, Quality Management), By Therapeutic Area (Cardiovascular, Orthopedic, Other Devices), By End User (OEMs, Pharmaceutical & Biopharmaceutical Companies), By Region – Industry Forecast 2026-2033

Class II (moderate complexity) devices, such as surgical gloves, diagnostic imaging, and infusion pumps are most commonly contracted out to contract manufacturers because they cover moderate levels of regulatory complexity and are applied in a wide variety of high-demand therapeutic areas.

The main drivers include the increased demand for medical devices, more OEMs outsourcing to reduce costs, searching for innovation, and the introduction of technology such as 3D Printing and automation.

Regulatory compliance creates challenges due to differences in worldwide standards. Manufacturers must adhere to both the FDA, EMA, and a multitude of other regulatory bodies, therefore it is essential to find partners who have experience in and understand compliance.

Although the economy has slowed, the medical device contract manufacturing market has managed to withstand the economic fluctuations. Increased outsourcing from OEMs and consistent demand for medical devices (including ventilators and high-demand IVD products) led to a significant share of the medical device market being added even during a recession in years like 2020.

The challenges facing the industry are of major concern given the complex regulatory requirements, which are coupled with supply chain disruptions globally, making production difficult, costly, and challenging for new devices to enter the market.

Global Medical Device Contract Manufacturing Market size was valued at USD 70.83 Billion in 2024 and is poised to grow from USD 78.9 Billion in 2025 to USD 187.15 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026–2033).

Thermo Fisher Scientific Inc. (United States), Jabil Inc. (United States), Flex Ltd. (United States), Plexus Corp. (United States), Sanmina Corporation (United States), Integer Holdings Corporation (United States), TE Connectivity Ltd. (Switzerland), Nipro Corporation (Japan), Onex Corporation (Celestica Inc.) (Canada), West Pharmaceutical Services, Inc. (United States), Benchmark Electronics Inc. (United States), EQT Group (Recipharm AB) (Sweden), Gerresheimer AG (Germany), Kimball Electronics, Inc. (United States), Nortech Systems Incorporated (United States), Carclo plc (United Kingdom), Nolato GW, Inc. (Sweden), Viant Medical Holdings, Inc. (United States), Tecomet, Inc. (United States), SMC Corporation (United States)

The key driver of the medical device contract manufacturing market is the increasing demand for cost-efficient production, allowing healthcare companies to outsource manufacturing, focus on innovation, reduce time-to-market, and meet the growing global demand for advanced medical devices.

A key market trend in the medical device contract manufacturing market is the adoption of advanced manufacturing technologies like automation, additive manufacturing (3D printing), and digitalization to improve precision, reduce costs, and accelerate product development cycles.

North America accounted for the largest share in the medical device contract manufacturing market, driven by a well-established healthcare infrastructure, high demand for innovative medical devices, strong regulatory support, and the presence of major medical device manufacturers and contract service providers.